Introduction
A suspension of 2′-hydroxyacetophenone or 5′-chloro-2′hydroxyacetophenone (10 mmol) and substituted cinnamaldehyde (13 mmol) in methanol (150 ml) were cooled in ice. An aqueous solution of sodium hydroxide (150 ml, 60%) was added dropwise to the stirred solution. The mixture was allowed to warm to room temperature and stirred for 22 h. The resulted suspension was diluted with ice and water, and acidified with dilute hydrochloric acid (2N). The precipitate was filtered off, washed with water and crystallized. Physical and chemical data are reported in Table 1 . 3f, 3h) A mixture of 2′-hydroxyacetophenone or 5′-chloro-2′hydroxyacetophenone (10 mmol), substituted cinnamaldehyde (10 mmol) and barium hydroxide octahydrate (15 mmol) in methanol (200 ml) was stirred at 50°C for 6 h. After cooling, the solvent was evaporated under reduced pressure. Water was added to the residue and the resulted suspension was acidified with dilute hydrochloric acid (6N). The precipitate was filtered off, washed with water and crystallized. Physical and chemical data are reported in Table 1 .
3-Hydroxy-2-styrylchromones (4a-h)
Hydrogen peroxide (22 ml, 35%) was added to a mixture of 1-(2-hydroxyphenyl)-5-phenyl-2,4-pentadien-1-ones (3a-h) (10 mmol), ethanol (70 ml) and dilute sodium hydroxide (20 ml, 1N). The mixture was stirred at 90°C for 5 h. After cooling, the reaction mixture was poured into ice water, and acidified with dilute hydrochloric acid (6N). The precipitate was filtered off, washed with water, chromatographed on a silica gel column eluting with dichloromethane and crystallized. Physical and chemical data are reported in Table 2 .
3-Methoxy-2-styrylchromones (5a-h)
Substituted 3-hydroxy-2-styrylchromones (4a-h) (10 mmol) were suspended in dry acetone (250 ml). Dry potassium carbonate (30 mmol) and dimethyl sulphate (20 mmol) were added. The mixture was refluxed for 5 h with stirring. After cooling, the acetone was evaporated under reduced pressure and water was added to the residue. The precipitate was filtered off, washed with water and crystallized. Physical and chemical data are reported in Table 3 .
Virology

Cells
HeLa (Ohio) cells were routinely grown at 37°C using Eagle's MEM supplemented with 100 mg/ml of streptomycin and 100 U/ml of penicillin G. 8% Heat-inactivated foetal calf serum (FCS) was added for cell growth (growth medium) and the concentration was reduced to 2% for cell maintenance (maintenance medium).
Compounds
Stock solutions were prepared in ethanol (1, 0.1 or 0.01 mg ml) and further diluted in tissue culture medium shortly before use.
Virus
HRV types 1B and 14 were purchased from ATCC. Virus stocks were prepared by inoculating HeLa (Ohio) cell monolayers at a low multiplicity of infection (0.1 PFU/cell). Infected cells were incubated at 33°C. When the viral-induced cytopathic effect involved most of the cells, the cultures were freeze-thawed three times and the clarified supernatants titred by plaque assay (essentially as described by Fiala & Kenny, 1966) . The virus was stored in aliquots at -80°C until used.
XTT assay for cellular cytotoxicity
A tetrazolium-based (XTT) colourimetric assay was used to measure the cytotoxicity of compounds. This assay is based on the cleavage of the yellow tetrazolium salt XTT to form an orange formazan dye by viable, active cells. The formazan dye formed is soluble in aqueous solutions and is directly quantified using a scanning multiwell spectrophotometer (Scudiero et al., 1988) . HeLa cells were seeded in 96 well tissue culture plates at 2×10 3 cells per well in 100 ml of growth medium, with or without compounds in N Desideri et al. 196 ©2003 International Medical Press (Silva et al., 1998 ) [lit. 154-156 (Silva et al., 1998 
H Cl 187-188 from EtOH 80 1630 (Silva et al., 1998 ) [lit. 181-183 (Silva et al., 1998 twofold dilutions, starting from the maximum soluble concentration in cell culture medium. Quadruplicate wells were used for each drug concentration to be tested. The plates were incubated for 3 days at 37°C in 5% CO 2 -air until the untreated monolayers were confluent (approximately 1.5×10 4 cells per well). Then, 50 ml of XTT labelling mixture were added to each well (final XTT concentration 0.15 mg/ml) and the cells incubated for 4 h at 37°C. The spectrophotometric absorbance of the samples was measured using an ELISA reader at 492 nm with a reference wavelength at 690 nm. Cytotoxicity was also scored microscopically, as morphological alterations, on the third day of incubation in the presence of compounds.
Determining the IC 50
The inhibitory concentration at 50% (IC 50 ) values were determined as described previously (Desideri et al., 1992) . Briefly, confluent monolayers of HeLa cells in 6-well plates were infected with a virus suspension producing approximately 100 plaques per well. After 1 h of incubation at 33°C, the virus inoculum was removed and the cells were overlaid with medium for plaques (Eagle's MEM containing 2% FCS, antibiotic, 0.1 mg/ml DEAE-dextran, 15 mM MgCl 2 and 0.7% agarose), in the presence or absence of fourfold dilutions of drugs. After 3 days of incubation at 33°C, the cells were stained with a neutral red solution at 0.2 mg/ml in pH 7.4 phosphate buffered saline and the Table 4 . Cytotoxicity and antirhinovirus activity of the new synthesized 1-(2-hydroxyphenyl)-5-phenyl-2,4-pentadien-1-ones (3a-h), 3-hydroxy-2-styrylchromones (4a-h) and 3-methoxy-2-styrylchromones (5a-h), and of the key compounds previously tested (1a, 2a, 2e)* plaques were counted. The IC 50 was expressed as the concentration of drug reducing the plaque number by 50% as compared to mock-treated control. It was calculated from a dose-response curve obtained by plotting the percentage of plaque reduction, with respect to the control plaque count, versus the logarithm of compound dose. Triplicate wells were utilized for each drug concentration.
Results
Chemistry 3-Hydroxy-2-styrylchromones (4a-h) and 3-methoxy-2styrylchromones (5a-h) were successfully prepared adopt-ing the strategies developed for the synthesis of the more extensively studied 3-hydroxy and 3-methoxyflavones. As shown in Figure 2, 1-(2-hydroxyphenyl) -5-phenyl-2,4-pentadien-1-ones (3a-h) were obtained from the corresponding 2′-hydroxyacetophenones and 4-substituted cinnamaldehyde by base-catalysed reaction. The condensation was usually performed at room temperature, in hydroalcoholic sodium hydroxide. Less soluble 4-nitro and 4-chloro derivatives (3d, 3f, 3h) were obtained with higher yields by mild heating of methanolic suspension, using barium hydroxide octahydrate as base.
The oxidative cyclization of 2′-hydroxycinnamylideneacetophenones (3a-h) to 3-hydroxy-2-styrylchromones (4a-h) was carried out with alkaline hydrogen peroxide. The 3-hydroxy-2-styrylchromones (4a-h) were then transformed into the 3-methoxy analogues (5a-h) by treatment with dimethyl sulphate in the presence of potassium carbonate. The analysis of the coupling constant value of the 1 H NMR established the trans configuration of Cα-Cβ double bond ( J α-β ≅16 Hz) of both 3-hydroxy and 3-methoxy-2styrylchromones.
Antiviral activity
3-Hydroxy-2-styrylchromones (4a-h), 3-methoxy-2styrylchromones (5a-h), and the synthesis intermediate 1-(2-hydroxyphenyl)-5-phenyl-2,4-pentadien-1-ones (3a-h) were tested in HeLa cell cultures infected with HRV 1B and 14, belonging to viral group B and A, respectively. The existence of two rhinovirus groups with different sensibility to antirhinovirus compounds suggests selecting one serotype from each group to identify a broad spectrum of antirhinoviruses. 4′,6-Dichloroflavan (BW683C) (Bauer et al., 1981) , an inhibitor of group B serotypes, was included as a control.
In preliminary studies, the cytotoxicity of the compounds was evaluated by measuring their effect on HeLa cell morphology and growth. Morphological alterations were scored microscopically, and the effect of the compounds on logarithmic cell growth was determined by the XTT colourimetric method (Scudiero et al., 1988) . Table 4 reports the maximum non-toxic concentrations of compounds, expressed as the highest dose tested that did not produce any cytopathic effect, or reduction on cell growth, after 3 days of incubation at 37°C. The values ranged from 3.12 to 100 µM. In general, the dichloro derivatives (3, 4, 5f) and the chloro, nitro derivatives (3, 4, 5h) were more toxic than the respective 4′-monosubstituted compounds (3, 4, 5b; 3, 4, 5d ). 1-(2-Hydroxyphenyl)-5-phenyl-2,4pentadien-1-one (3a) and 6-chloro-3-methoxy-2styrylchromones (5e) did not show any cytotoxicity at the highest dose tested (100 µM).
The inhibitory activity of the compounds on rhinovirus replication was evaluated in a plaque reduction assay, starting from the maximum non-toxic concentration. The compound concentration required to produce a 50% reduction in plaque numbers with respect to mock-treated virusinfected cultures (IC 50 ) was calculated by dose-response plots using the linear regression technique (Table 4 ). When the IC 50 value was higher than the maximum non-toxic concentration, the percentage inhibition at this dose was reported in parentheses. All the tested compounds interfered with the replication of both serotypes, with the exception of 6-chloro-3-hydroxy-4′-methoxy-2-styrylchromone (4g) and 6-chloro-3-methoxy-2-styrylchromones (5e) which were ineffective against serotype 14 as the reference compound (BW683C) . Several compounds (3c, 3e, 3g, 4a,   4c, 4e, 4h, 5b, 5e ) caused a reduction in viral plaque size of HRV1B, in addition to an effect on plaque number; only 5h alters the plaque size of HRV 14.
Discussion
A preceding study indicated that 2-styrylchromones constitute a new class of antirhinovirus flavonoids (Desideri et al., 2000) . Moreover, several 2-styrylchromones exhibited activity against both groups A and B of HRVs (Desideri et al., 2000) ; this differed from previously tested flavonoids.
In the present study, we describe the synthesis and antirhinovirus activity of 3-hydroxy and 3-methoxy derivatives designed to improve the potency of 2-styrylchromones previously studied. Our data indicate that 1-(2-hydroxyphenyl)-5-phenyl-2,4-pentadien-1-ones (3a-h), which are intermediates in the synthesis, 3-hydroxy-2styrylchromones (4a-h) and 3-methoxy-2-styrylchromones (5a-h) are effective in vitro inhibitors of HRV 1B and 14 replication.
When compared to previously tested 2,4-pentadien-1ones 3-hydroxy substituted on the chain (compounds 1a-g) (Desideri et al., 2000) , 2,4-pentadien-1-ones (3a-h) showed a slightly reduced activity against HRV 1B and a remarkably increased effect against HRV 14. In contrast, we observed that the introduction of a hydroxy or a methoxy substituent in 3 position of the chromone ring (4a-h and 5a-h) generally enhanced the antiviral potency against both tested serotypes. In fact, by comparison with the results previously obtained for 3-unsubstituted 2styrylchromones (2a-h) (Desideri et al., 2000) , only the 3substituted 4′-nitro-2-styrylchromones (4d and 5d) were less potent than the corresponding analogue (2e) without substituent in 3 position. 4′-Nitro-2-styrylchromone (2e) was the most active compound among 3-unsubstituted 2styrylchromones (2a-h), with IC 50 values of 3.9 and 1.3 µM against HRV 1B and 14, respectively (Desideri et al., 2000) .
For synthetic flavones, a positive correlation between antipicornavirus activity and the presence of a 3-hydroxy or a 3-methoxy group was already reported (Desideri et al., 1995) . In addition, the antiviral effect of flavones was further increased by the presence of a chlorine atom on 6 position of the chromone skeleton (Desideri et al., 1995) . Therefore we synthesized and tested the 6-chloro 3hydroxy-and 3-methoxy-2-styrylchromones (4e-h and 5e-h). In contrast to data previously obtained, the introduction of the 6-chlorine atom generally led to reduced activity in the series of 3-substituted-2-styrylchromones. Only when a strong electron-withdrawing nitro group is present at 4′ position (4d and 5d), 6-chloro substitution results in analogues (4h and 5h) with higher potency against both serotypes. Compounds 4h and 5h thus emerged as the most potent 3-hydroxy-and 3-methoxy-2-styrylchromones, but at same time they exhibited significant cytotoxicity. On the other hand, the corresponding 2,4-pentadien-1-one (3h), besides a potent inhibitory effect against both serotypes, showed a slightly lower cytotoxicity. Although the selective inhibitory effect of active compounds does not seem very high, it must be observed that all compounds had a low solubility in the cell culture medium. Therefore, the therapeutic index could not be calculated, since the 50% cytotoxic concentration was higher than the limit of their aqueous solubility.
In conclusion, the new data confirm 2-styrylchromones as a new class of antirhinovirus flavonoids that are active against both HRV groups A and B. As expected, the introduction of a 3-hydroxy or a 3-methoxy group was found to improve antirhinovirus activity.
